Furthermore, since for most tumors it is difficult to specify a truly tumor specific promoter we combined the tumor-/tissue-specific promoter COX-2 with a proliferation-associated Ki-67 promoter to target viral replication and lysis to the transcriptional intersection of these two promoters. Here, MKI67 is linked to neoplasm.